NCT07104617View on ClinicalTrials.gov

Study of TY-302 Capsules Combined With Abiraterone in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

November 30, 2026

Conditions

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Interventions

DRUG

TY-302

Take the specified dose (75mg or 100mg) orally once a day. Take it on an empty stomach in the morning with about 200 mL of warm water.

DRUG

Abiraptor

Take orally, 1000mg each time, once a day. Take it on an empty stomach in the morning with warm water, or take it orally at least two hours after fasting.

Trial Locations (1)

Unknown

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors

lead

TYK Medicines, Inc

INDUSTRY